High Times, Weighty Issues
A number of factors – including this new one – have weighed on Canadian cannabis stocks this year despite the buzz surrounding impending legalization. Does… Read More »High Times, Weighty Issues
A number of factors – including this new one – have weighed on Canadian cannabis stocks this year despite the buzz surrounding impending legalization. Does… Read More »High Times, Weighty Issues
A little over the half-way mark of 2018, these are the five best performing marijuana stocks with market caps over $200 million – and five… Read More »The Current – And Upcoming – Hot Pot Stocks
Canada-based Tilray is the latest cannabis firm to file for an initial public offering on the NASDAQ. Here’s a look at this new cannabis stock… Read More »Better Know This New Cannabis IPO
With its recently announced plan to add a new facility focused on the development and production of cannabis-infused beverages and edibles, this firm is poised… Read More »Canada’s Intriguing New Big Pot Player
While they didn’t receive much news coverage, several developments over the last few weeks may have provided the most clarity there’s been in quite some… Read More »A Lifting Haze?
This Canadian medical cannabis company’s stock has been on the rise over the last month as that country moves ever closer to legalizing marijuana for… Read More »High(er) Times Ahead For This (Undervalued?) Medical Marijuana Stock?
The Supreme Court recently paved the way for states to legalize sports betting – opening up a market that is estimated to be three times… Read More »Sports Gambling: The Marijuana Boom On Steroids?
On June 7th, Canada’s Senate is set to vote on bill C-45 (a.k.a. the Cannabis Act), which, if passed, would legalize recreational marijuana use. With… Read More »Canada Cannabis Considerations
2018 has been a year ripe with marijuana stock takeover targets. When it comes to the next big marijuana acquisition, here’s who might be the… Read More »The Next Big Marijuana Merger
Of the three marijuana-based drugs that have been approved by the FDA to date, none have been big commercial successes. In contrast, this cannabinoid drug,… Read More »Blockbuster Or Bust?